FDA Clears ViewRay MR-Radiotherapy Device for Premarket

Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

The FDA has cleared an MRI-guided radiation therapy system developed by the Cleveland, OH-based ViewRay, Inc. for premarket notification.

Last year, the administration approved the ViewRay treatment planning and delivery software for premarketing as well. Now the company says its combined solution soon will be commercially available for the treatment of simultaneous MR and radiotherapy for cancer patients.

ViewRay installed research versions of its initial systems in various locations throughout the United States this year.